Physician profile
Daniel Miles
NPI 1124525258
$26,584.36
in general payments reported to CMS, 2019-2025
18 companies · $8,612 in 2025
The $8,612 reported for 2025 was more than what 76% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $7,174 · 2024: $11K · 2025: $8,612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,542 · Education: $5,130 · Grant: $5,000 · Food and Beverage: $4,912 · Consulting Fee: $3,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,542.20 |
| Education | $5,129.99 |
| Grant | $5,000.00 |
| Food and Beverage | $4,912.17 |
| Consulting Fee | $3,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $12,947.68 | 2023-2025 | Evos, Trigen Intertan, Journey II |
| Stryker Corporation | $4,536.99 | 2023-2025 | Mako, Pro, T2 Alpha |
| Polynovo North America LLC | $3,968.85 | 2025 | Novosorb Btm |
| Globus Medical, INC. | $2,064.29 | 2023-2025 | Precice Intramedullary Limb Lengthening System, A/R Femoral Nail, Anthem |
| Arthrex, INC. | $766.32 | 2023-2025 | Distal Extremities Implants Trauma Syndesmosis Tightropes |
| Alon Medical Technology | $656.38 | 2025 | |
| Depuy Synthes Sales INC. | $551.62 | 2024-2025 | Na, Va-Lcp |
| Biocomposites INC | $149.90 | 2025 | Stimulan |
| Seapearl East, INC | $147.30 | 2023 | |
| Bioventus LLC | $146.89 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Curvafix, INC. | $139.58 | 2025 | Curvafix Im Implant |
| Medical Device Business Services, INC. | $129.99 | 2024 | |
| Bone Support INC. | $125.99 | 2025 | Cerament G, Ceramentbone Void Filler |
| Ethicon US, LLC | $100.23 | 2024 | Dermabond Prineo, Stratafix, Vistaseal |
| Merck Sharp & Dohme LLC | $91.69 | 2024 | Keytruda |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $29.58 | 2023 | Tecentriq |
| Heron Therapeutics, INC. | $15.90 | 2024 | Zynrelef |
| Agios Pharmaceuticals, INC. | $15.18 | 2023 | Pyrukynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Miles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.